HIGHLIGHTS
- who: September and colleagues from the Shantou University, China have published the research: Micro brillar-associated protein 2 is a prognostic marker that correlates with the immune microenvironment in glioma, in the Journal: (JOURNAL)
- what: The authors investigated the influence of MFAP2 in patient survival and the correlation between MFAP2 expression and clinicopathological elements of glioma.
- how: The authors investigated the prognostic value of MFAP2 in glioma using a nomogram model. This study was carried out in accordance with the Declaration of Helsinki.
- future: It affords crucial insight into the roles . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.